Medtronic files PMA application for Talent graft:
This article was originally published in Clinica
Executive Summary
Medtronic has filed the final module of a US PMA application for its Talent abdominal stent graft system. The Talent graft is a minimally-invasive device for the treatment of abdominal aortic aneurysm (AAA), designed to offer broad patient applicability and ease of use. The Minneapolis, Minnesota-based company said that the device would complement its AneuRx AAAdvantage stent graft. The submission contained data from a clinical trial in which patients revceiving the Talent graft experienced lower rates of death, myocardial infarction, respiratory failure, paraplegia, and blood loss, compared with subjects treated with open surgery, at 12 months.